JP3494320B2 - Ulcerative colitis suppressing composition - Google Patents

Ulcerative colitis suppressing composition

Info

Publication number
JP3494320B2
JP3494320B2 JP03015095A JP3015095A JP3494320B2 JP 3494320 B2 JP3494320 B2 JP 3494320B2 JP 03015095 A JP03015095 A JP 03015095A JP 3015095 A JP3015095 A JP 3015095A JP 3494320 B2 JP3494320 B2 JP 3494320B2
Authority
JP
Japan
Prior art keywords
weight
parts
ulcerative colitis
starch
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP03015095A
Other languages
Japanese (ja)
Other versions
JPH08198757A (en
Inventor
達也 森田
利圭 猪飼
晃 大橋
誠一 笠岡
修八 桐山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP03015095A priority Critical patent/JP3494320B2/en
Publication of JPH08198757A publication Critical patent/JPH08198757A/en
Application granted granted Critical
Publication of JP3494320B2 publication Critical patent/JP3494320B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、潰瘍性大腸炎を抑制す
ることのできる組成物、特に食品組成物に関する。本発
明においては、ハイアミローススターチ(high amylose
starch)(以下、「HAS」と記す)が潰瘍性大腸炎を
抑制することのできる有効成分として含有される。
TECHNICAL FIELD The present invention relates to a composition capable of suppressing ulcerative colitis, particularly a food composition. In the present invention, high amylose starch
starch) (hereinafter referred to as "HAS") is contained as an active ingredient capable of suppressing ulcerative colitis.

【0002】[0002]

【従来の技術】原因不明の大腸の炎症性疾患に、主とし
てその粘膜をびまん性に侵し、しばしば多数のびらんや
潰瘍を伴う潰瘍性大腸炎がある。この潰瘍性大腸炎は、
従来、欧米に比較的に多い疾炎であったが、最近わが国
でも漸増する傾向にある。この原因は食事や生活様式の
変化との関係も考えられているが、未だ確証されていな
い。従って、潰瘍性大腸炎の治療は原因療法によるより
も保存療法で行われている。一般に、保存療法は急性活
動期をなるべく早く鎮静化し、安定期を維持することに
あり、大部分の症例ではまず保存療法を行うことが原則
となっている。そして、急性活動期の食事としては栄養
に注意して、なるべく低残渣食を与えるのが良いとされ
ている。これまで潰瘍性大腸炎などの炎症性腸疾患に対
する栄養管理は、中心静脈栄養が主体で行われており、
経腸栄養としては成分栄養または低残渣食が奨励されて
きた。しかしながら、その炎症性腸疾患が安定期に入る
と、再発抑制のため、経腸栄養としては低残渣食のまま
が有効なのかあるいは食物繊維の添加食がよいのかにつ
いて、また添加される食物繊維の種類により大腸粘膜に
およぼす効果がどのような差異があり、どの食物繊維が
よいのかなどについては、まだ結論がでていない(日本
静脈経腸栄養研究会誌 第8巻 平成5年2月号)。
2. Description of the Related Art Inflammatory diseases of the large intestine of unknown cause include ulcerative colitis, which mainly diffuses its mucous membrane and often has many erosions and ulcers. This ulcerative colitis
Conventionally, there were relatively many cases of inflammation in Europe and the United States, but recently there is a tendency to gradually increase in Japan. The cause is considered to be related to changes in diet and lifestyle, but it has not been confirmed yet. Therefore, treatment of ulcerative colitis is more conservative than causative. In general, conservative therapy consists in calming the acute activity phase as soon as possible and maintaining a stable phase. In most cases, the conservative therapy is the first principle. As a diet during the acute activity period, it is said that it is good to give a low-residue diet while paying attention to nutrition. Up to now, nutritional management for inflammatory bowel diseases such as ulcerative colitis has been performed mainly by central parenteral nutrition,
Elemental nutrition or low-residue diets have been encouraged as enteral nutrition. However, when the inflammatory bowel disease enters a stable phase, it is effective to keep the low-residue diet as an enteral nutrition or to supplement the dietary fiber to prevent recurrence. The effect on the mucous membranes of the large intestine depending on the type, and which dietary fiber is better, have not been concluded yet (Journal of Parenteral and Enteral Nutrition Vol. 8, February 1993 issue). .

【0003】現在、食物繊維の摂取量は食生活の変化に
伴い低下しているが、最近は食物繊維の消化管および代
謝に与える影響が見直されつつある。しかし、食物繊維
は、その種類により生理作用に差があり、期待した効果
が得られないばかりか、かえって増悪するケースもあ
る。また、効果が示されるには多量に摂取しなければな
らない場合もあり、さらに食感・味・色が劣るために摂
取者に好まれず、また食品としての質が落ち長期間摂取
しにくいという問題も生じている。
At present, the intake of dietary fiber is decreasing with changes in dietary habits, but recently, the influence of dietary fiber on the digestive tract and metabolism is being reviewed. However, the physiological effects of dietary fiber differ depending on the type, and not only the expected effect cannot be obtained, but there is also a case where the fiber deteriorates. In addition, it may be necessary to ingest a large amount to show the effect, and it is not liked by the ingestor due to its poor texture, taste, and color, and it is difficult to ingest for a long time because the quality of the food is poor. There are also problems.

【0004】一方、最近HASといわれるアミロース含
量の高い澱粉が開発され注目されている。いわゆるHA
Sは、フイルム、食物、工業製品などの種々の組成物に
好ましい性質を付与することが知られている。例えば、
HASはソーセージの皮、砂糖菓子、ゲル強度を増加し
た食品、ポリエチレンビニルアルコールのようなポリマ
ーにラミネートしてガスバリヤー性の優れたフイルムな
どとして用いられることが知られている(WO 94/
03049号公報)。また、極力蛋白質を除去した食品
が必要とされる腎臓患者などのために、HASを通常の
澱粉に混和して、押し出し造粒して、低蛋白質の米様食
品とすることが提案されている(特開昭64−3726
2号公報)。
On the other hand, recently, a starch called HAS having a high amylose content has been developed and attracts attention. So-called HA
S is known to impart favorable properties to various compositions such as films, foods and industrial products. For example,
HAS is known to be used as sausage skins, sugar confectionery, foods with increased gel strength, films laminated with a polymer such as polyethylene vinyl alcohol and having excellent gas barrier properties (WO 94 /
03049). In addition, it has been proposed to mix HAS with ordinary starch and extrude and granulate it to obtain a low-protein rice-like food for kidney patients and the like who need a protein-free food as much as possible. (JP-A-64-3726
No. 2).

【0005】[0005]

【発明が解決しようとする課題】本発明者らは、上述の
ような大腸炎療法の現状に鑑み、潰瘍性大腸炎抑制物質
を探索する一方、HASについても研究を重ね、このも
のが潰瘍性大腸炎の発生を抑制し治療する作用を有する
ことを見だした。従って、本発明の課題は潰瘍性大腸炎
抑制組成物を提供することにある。
In view of the current state of colitis therapy as described above, the present inventors have searched for ulcerative colitis-inhibiting substances, and have also conducted research on HAS, which is ulcerative. It has been found that it has the effect of suppressing the occurrence of colitis and treating it. Therefore, an object of the present invention is to provide a composition for suppressing ulcerative colitis.

【0006】[0006]

【課題を解決するための手段】すなわち、本発明は、H
ASを潰瘍性大腸炎の発症を抑制し、治療するための有
効成分として種々の材料、特に食品材料に配合してなる
潰瘍性大腸炎抑制組成物に関する。本発明の組成物は種
々の形体に成形して日常手軽に食することができる。
That is, the present invention provides H
The present invention relates to an ulcerative colitis-suppressing composition obtained by incorporating AS into various materials, particularly food materials, as an active ingredient for suppressing and treating the development of ulcerative colitis. The composition of the present invention can be molded into various shapes and can be easily eaten daily.

【0007】以下、本発明を詳しく説明する。HAS
は、アミロース含量の高い澱粉の総称であり、アミロー
スを40〜90重量%、好ましくは50〜90重量%、
さらに好ましくは70〜90重量%含んだHASが用い
られる。且つ、HASは食物繊維と別異物質であるが、
食物繊維の定量法の1つとして用いられているProskyら
の総食物繊維定量法ジャアナルオブ アソシエーション
オブ オフィシャル アナリティカル ケミスツ(Jo
urnal of Association of official Analytical chemis
ts 71, (5), 1017 (1988)) を行ない、難消化性成分を
得た時25〜40重量%を示すHASが好ましい。この
ようなHASの原料としては特に制限はなく、とうもろ
こし、じゃがいも、米、小麦、マメ等の植物性の生澱
粉、澱粉分解物、およびこれらの混合物があげられる。
もともとアミロース含有量の高い澱粉のほか、変異種も
含むものである。また、WO 94/03049号公報
に記載されるようなハイブリッドとうもろこしから好ま
しく製造することができる。
The present invention will be described in detail below. HAS
Is a generic term for starch having a high amylose content, and contains 40 to 90% by weight of amylose, preferably 50 to 90% by weight,
More preferably, HAS containing 70 to 90% by weight is used. And HAS is a different substance from dietary fiber,
Prosky et al.'S Total Dietary Fiber Assay, which is used as one of the dietary fiber quantification methods. Ja Anal of Association of Official Analytical Chemistry (Jo
urnal of Association of official Analytical chemis
ts 71 , (5), 1017 (1988)), and HAS showing 25 to 40% by weight is preferred when an indigestible component is obtained. The raw material for such HAS is not particularly limited, and examples thereof include corn, potato, raw vegetable starch such as rice, wheat, and legume, a decomposed product of starch, and a mixture thereof.
Originally, in addition to starch with a high amylose content, it also contains mutants. Further, it can be preferably produced from hybrid corn as described in WO 94/03049.

【0008】HASは、上記したように種々の工業製品
に好ましい物性を付与することが知られているが、この
ものが潰瘍性大腸炎抑制作用を有することは従来知られ
ていなかった。しかし、本発明者らの研究によると、上
述のようなHASを他の食品材料に配合し、摂取可能な
食品の10〜50重量%、好ましくは20〜40重量%
がHASである食品組成物とし、これを成人1日当たり
10〜70g、好ましくは20〜40gを継続して摂取
をつづけるとき、潰瘍性大腸炎の発症や抑制、治療効果
が認められることが見だされた。
[0008] HAS is known to impart preferable physical properties to various industrial products as described above, but it has not hitherto been known that HAS has an ulcerative colitis suppressing action. However, according to the study by the present inventors, the HAS as described above is mixed with other food materials, and 10 to 50% by weight, preferably 20 to 40% by weight of the ingestible food.
Is a HAS food composition, and when it is continuously ingested at an adult daily dose of 10 to 70 g, preferably 20 to 40 g, it is found that the onset, suppression, and therapeutic effects of ulcerative colitis are observed. Was done.

【0009】本発明では、HASを配合する食品材料は
特に限定されるものではなく、他の糖類、脂質、蛋白
質、さらにこれらに必要に応じてビタミン、ミネラルの
ようなその他の添加剤を添加してHAS含有食品組成物
とすることができる。このようなHAS含有組成物は摂
取し易い形体とすればよく、通常の食品形体としては例
えばクッキー、パン類、ケーキ、カロリーメイトTMのよ
うなブロック菓子、ウエハース菓子、スチック菓子、乳
製品、ドリンク類、味噌等の種々の食品とすることがで
きるほか、例えば適当な増量剤、賦形剤などを用いて錠
剤状、塊状、液状、シロップ状、顆粒状、粉末状とした
いわゆる健康食品形態にすることもきる。HASは、食
物繊維とくらべて食感、味、色等が優れているのでこれ
を含有する組成物は長期に亘り多量の摂取が可能であ
り、潰瘍性大腸炎の発症を抑制し、治療することができ
る。本発明におけるHASの潰瘍性大腸炎抑制作用を試
験例に基づいて詳しく説明する。
In the present invention, the food material containing HAS is not particularly limited, and other sugars, lipids, proteins and, if necessary, other additives such as vitamins and minerals may be added. HAS-containing food composition. Such a HAS-containing composition may be in an easily ingestible form, and typical food forms include, for example, cookies, breads, cakes, block confectioneries such as Calorie Mate , wafer confectionery, stick confectionery, dairy products, drinks. In addition to various foods such as foods, miso, etc., for example, in the form of so-called health foods made into tablets, lumps, liquids, syrups, granules, powders, etc. by using appropriate fillers, excipients, etc. You can also do it. HAS is superior in texture, taste, color, etc. to dietary fiber, so that a composition containing it can be taken in large amounts over a long period of time and suppresses and treats the development of ulcerative colitis. be able to. The ulcerative colitis suppressing effect of HAS in the present invention will be described in detail based on test examples.

【0010】[0010]

【試験例1】Sprague-Dawley系雄性ラット(7週齢)を
用い、7日間、通常のコーンスターチ(corn starch)
(以下、CSと記す)を炭水化物源とする標準飼料で予
備飼育し、異常のない個体を選別し、1群12匹として
実験に供した。なお、HASはHi-MaizeTM(Starch Aust
ralasia 社製、アミロース含量約70重量%) を用い
た。上記ラットに0.25mlの50重量%エタノール
に溶解した2,4,6-トリニトロベンゼンスルホン酸(TN
B)30mgを経肛門的に投与して大腸炎を誘発した
(Gastroenterology 96, 795〜803 (1989))。なお、無
処置群には、TNBの代わりに0.25mlの生理食塩
水のみを投与した。
[Test Example 1] Male Sprague-Dawley rats (7 weeks old) were used for 7 days and normal corn starch was added.
(Hereinafter, referred to as CS) was preliminarily fed with a standard feed containing carbohydrate as a carbohydrate source, individuals without abnormality were selected, and 12 animals per group were subjected to the experiment. HAS is Hi-Maize TM (Starch Aust
Amylose content of about 70% by weight manufactured by ralasia) was used. To the above rats, 2,4,6-trinitrobenzenesulfonic acid (TN) dissolved in 0.25 ml of 50% by weight ethanol was added.
B) 30 mg was administered transanally to induce colitis (Gastroenterology 96, 795-803 (1989)). In the untreated group, 0.25 ml of physiological saline was administered instead of TNB.

【0011】TNB投与翌日からCS飼料に15重量%
または30重量%のHASを添加したHAS飼料、また
はCS飼料に8.3重量%のビート食物繊維(beet diet
aryfiber)(以下、BDFと記す)を添加したBDF飼
料を水とともに2週間自由摂取させた。なお、無処置群
には標準飼料を与えた。標準飼料HAS飼料およびBD
F飼料の組成については表1に示す。
15% by weight from the day after TNB administration to CS feed
Or HAS feed containing 30% by weight of HAS, or 8.3% by weight of beet diet in CS feed.
BDF feed supplemented with ary fiber) (hereinafter referred to as BDF) was freely taken with water for 2 weeks. The standard diet was given to the untreated group. Standard feed HAS feed and BD
The composition of F feed is shown in Table 1.

【0012】[0012]

【表1】 * AIN-76組成(ジャアナル オブ ニュートリション(Journal of Nutrition 10 7 、1340)) に準じた。[Table 1] * Pursuant to AIN-76 composition (Jaanaru of Nutrition (Journal of Nutrition 10 7, 1340 )).

【0013】各検体をTNB投与2週間後に屠殺し、各
々の検体につき、剖検時の大腸組織の肉眼所見(マクロ
スコア1−5)、大腸組織中の全ミエロペルオキシダー
ゼ活性量、及び血清トランスグルタミナーゼ活性を調べ
た。大腸組織の肉眼所見は、Morrisら(ガストロエンテ
ロロジイ(Gastroenterology) 96、795 (1989))の方法
に従って、またミエロペルオキシダーゼ活性はKrawisz
ら(ガストロエンテロロジイ(Gastroenterology 87
1344、(1984))、血清トランスグルタミナーゼ活性はジ
ャアナル・オブ・クリニカル・ガストロエンテロロジイ
(Journal of Clinical Gastroenterology 12、400 、
(1990))の方法に従って測定した。有意差検定には Stu
dent's t-test を用いた。
Each sample was sacrificed 2 weeks after administration of TNB, and macroscopic findings (macroscore 1-5) of large intestine tissue at autopsy, total myeloperoxidase activity in large intestine tissue, and serum transglutaminase activity of each sample were sacrificed. I checked. Macroscopic findings of colorectal tissue were performed according to the method of Morris et al. (Gastroenterology 96 , 795 (1989)), and myeloperoxidase activity was determined by Krawisz.
Gastroenterology 87 ,
1344, (1984)), serum transglutaminase activity was measured by Jaanal of Clinical Gastroenterology 12 , 400,
(1990)). Stu for significance test
dent's t-test was used.

【0014】(1) 肉眼所見 図1に示すように下記のマクロスコア基準に従い評価を
行った結果、剖検時における大腸組織の潰瘍について3
0%HAS飼料群は、標準飼料群に対して35%程度改
善されており、両群間には統計学上有意な差(p<0.
05)が認められた。 肉眼マクロスコア評価基準 0 異常なし 1 局在性充血(潰瘍なし)が観察される 2 線状潰瘍(明らかな炎症反応はない)が観察される 3 1ヵ所のみに炎症反応を伴った潰瘍が観察される 4 2ヵ所以上で潰瘍あるいは炎症部が観察される 5 2ヵ所以上で潰瘍および炎症の両方が比較的広い領
域で観察される あるいは直腸の縦方向に沿って1cm以上の広がりを持
つ大きな潰瘍および炎症部が1ヵ所に観察される
(1) Macroscopic Findings As shown in FIG. 1, the results of evaluation according to the following macroscore criteria showed ulcer of the large intestine tissue at autopsy 3
The 0% HAS feed group is improved by about 35% with respect to the standard feed group, and a statistically significant difference (p <0.
05) was recognized. Macroscopic macroscopic evaluation criteria 0 No abnormality 1 Localized hyperemia (no ulcer) is observed 2 Linear ulcer (no apparent inflammatory reaction) is observed 3 Ulcer with inflammatory reaction is observed only in 1 place Ulcer or inflamed area is observed at 42 or more sites 52 both ulcer and inflammation are observed at a relatively large area at 52 or more sites or a large ulcer having a spread of 1 cm or more along the longitudinal direction of the rectum And an inflamed area is observed in one place

【0015】なお、表2及び図2に示すように、各試験
飼料を2週間摂取した後のラットの体重増加量ならびに
飼料摂取量は、無処置群で有意に高い値を示したが、T
NBを投与した各試験群間の体重の増加量、飼料摂取量
に差は認められなかった。
As shown in Table 2 and FIG. 2, the weight gain and the feed intake of the rats after ingesting each test feed for 2 weeks showed significantly high values in the untreated group.
No difference was found in the amount of increase in body weight and the amount of feed intake between the test groups administered with NB.

【0016】[0016]

【表2】 [Table 2]

【0017】(2) ミエロペルオキシダーゼ活性 炎症マーカーである全大腸組織中のミエロペルオキシダ
ーゼ活性量は、図3に示されるようにTNB無処置群を
除き、30重量%HAS飼料群で最も低値(CS飼料群
に対し約40%の減少、p<0.05)を示した。ま
た、15重量%HASおよび8.3重量%BDF飼料群
においてもCS飼料群に対し、それぞれ約18%および
22%の活性量の低下が認められた。
(2) Myeloperoxidase activity As shown in FIG. 3, the amount of myeloperoxidase activity in the whole large intestine tissue, which is an inflammatory marker, was the lowest (CS) in the 30% by weight HAS feed group except for the TNB-untreated group. It showed a decrease of about 40% with respect to the feed group, p <0.05). Further, in the 15% by weight HAS and 8.3% by weight BDF feed groups, about 18% and 22% decrease in the active amount was observed as compared with the CS feed group, respectively.

【0018】(3) 血清中のトランスグルタミナーゼ活性 D'Argenio らは血清中のトランスグルタミナーゼ活性と
潰瘍性大腸炎による傷害の程度との間には明らかな逆相
関関係が認められると報告している(ジャアナル・オブ
・クリニカル・ガストロエンテロロジイ(J.Clin.Gastro
enterology 12400 (1990) およびスカンジナビアン・
ジャアナル・オブ・ガストロエンテッロジイ(Scand.J.G
astroenterol) 27、111 (1992))。従って、血清中のト
ランスグルタミナーゼ活性は、潰瘍性大腸炎の状態を把
握する上でよい指標になり得るものと考えられる。
(3) Serum transglutaminase activity D'Argenio et al. Reported that a clear inverse correlation was observed between serum transglutaminase activity and the degree of injury due to ulcerative colitis. (J.Clin.Gastro
enterology 12 400 (1990) and Scandinavian
Ja-anal of Gastroentello dii (Scand.JG
astroenterol) 27 , 111 (1992)). Therefore, it is considered that the transglutaminase activity in serum can be a good index for understanding the state of ulcerative colitis.

【0019】結果は図4に示すように、30重量%HA
S飼料群の活性はCS飼料群に比べ約1.8倍上昇して
おり、両群間の活性には差が認められた(p<0.0
5)。また30重量%HAS飼料群とTNB無処置群間
の活性に差はなかった。一方、15重量%HASおよび
8.3重量%BDF飼料群の血清トランスグルタミナー
ゼ活性においてもCS飼料群に対し、それぞれ1.5 倍、
1.4 倍の活性値の上昇が認められた。 これらの実験結
果から、HASは潰瘍性大腸炎に対し組織学的な改善作
用を示すだけでなく、炎症の抑制作用、また潰瘍性大腸
炎の診断マーカーとなりうる血清トランスグルタミナー
ゼ値の改善作用をも有することが明らかになった。一
方、食物繊維であるBDFには改善作用は認められず、
炎症マーカー、血清トランスグルタミナーゼ値において
も有意な改善効果は認められなかった。
The results are as shown in FIG.
The activity of the S feed group was about 1.8 times higher than that of the CS feed group, and there was a difference in the activity between the two groups (p <0.0.
5). In addition, there was no difference in activity between the 30 wt% HAS feed group and the TNB untreated group. On the other hand, the serum transglutaminase activity of the 15 wt% HAS and 8.3 wt% BDF feed groups was 1.5 times that of the CS feed group, respectively.
A 1.4-fold increase in activity value was observed. From these experimental results, HAS has not only a histological improving effect on ulcerative colitis but also an suppressing effect on inflammation and an improving effect on serum transglutaminase level which may be a diagnostic marker for ulcerative colitis. It became clear to have. On the other hand, BDF which is a dietary fiber has no improvement effect,
No significant improvement effect was observed on inflammation markers and serum transglutaminase levels.

【0020】[0020]

【試験例2】表3に示される組成を持ち、総食物繊維定
量法によって得られる難消化性成分をほぼ等しくして2
種類のビスケットを常法に従って調製した。得られたビ
スケットを20人のパネラーを対象にして官能試験を実
施した。試験項目は色、味、食感の3項目とし、各項目
に関して好ましい方を選択させた。その後、2点嗜好試
験法の検定表に基づいて検定を行った。なお、食物繊維
含有量は日本食物繊維成分表(科学技術庁資源調査会
編)より算出した。また、HASとしては Hi-Maize TM
を使用した。
[Test Example 2] The composition shown in Table 3 was used, and the indigestible components obtained by the total dietary fiber quantification method were made substantially equal to each other.
Biscuits of various types were prepared according to a conventional method. The obtained biscuit was subjected to a sensory test for 20 panelists. The test items were three items of color, taste and texture, and the preferred one was selected for each item. Then, the test was performed based on the test table of the two-point preference test method. The dietary fiber content was calculated from the Japanese dietary fiber composition table (edited by the Science and Technology Agency, Resource Research Committee). Also, as HAS, Hi-Maize TM
It was used.

【0021】[0021]

【表3】 [Table 3]

【0022】得られた試験結果を表4に示した。表4に
示したとおり、色、味、食感ともにHAS(Hi-maize)
含有のビスケットの方が良く、特に食感は対象区に比べ
試験区(Hi-maize含有)のビスケットが有意に好まれる
結果が得られた。尚、小麦ふすま中の難消化性成分はPr
oskyらの方法に基づき定量を行った。
The test results obtained are shown in Table 4. As shown in Table 4, HAS (Hi-maize) for color, taste and texture
The biscuits containing the biscuits were better, and the texture was particularly favored by the biscuits in the test group (containing Hi-maize) compared to the target group. The indigestible ingredient in wheat bran is Pr
Quantification was performed based on the method of Osky et al.

【0023】[0023]

【表4】 以下、実施例をあげて本発明を具体的に説明する。[Table 4] Hereinafter, the present invention will be specifically described with reference to examples.

【0024】[0024]

【実施例1】HAS粉末にコーンスターチの5重量%水
溶液を等量添加し、ニーダーにより混練して約300μ
の顆粒に造粒、温風で乾燥して潰瘍性大腸炎の予防・治
療に有用な顆粒形態の製品を得た。
Example 1 An equal amount of a 5% by weight aqueous solution of corn starch was added to HAS powder, and the mixture was kneaded with a kneader to give about 300 μm.
The granules were granulated and dried with warm air to obtain a granular product useful for the prevention and treatment of ulcerative colitis.

【0025】[0025]

【実施例2】HAS粉末にコーンスターチを等量加え、
さらに賦形剤として乳糖を少量加え、混合したものを常
法により打錠機にて成形して潰瘍性大腸炎の予防・治療
に有用な錠剤形態の製品を得た。
Example 2 An equal amount of corn starch was added to HAS powder,
Further, a small amount of lactose was added as an excipient and the mixture was molded by a tableting machine by a conventional method to obtain a tablet-shaped product useful for the prevention and treatment of ulcerative colitis.

【0026】[0026]

【実施例3】小麦粉160重量部、食塩4重量部、HA
S粉末10重量部に水32重量部を加えて混捏し、得ら
れた麺生地を麺帯機により圧延し、切り出し機によって
麺線に切り出し乾燥してHAS入り麺を得た。
Example 3 160 parts by weight of wheat flour, 4 parts by weight of salt, HA
32 parts by weight of water was added to 10 parts by weight of S powder and kneaded, and the obtained noodle dough was rolled by a noodle band machine, cut into noodle strings by a cutting machine and dried to obtain HAS-containing noodles.

【0027】[0027]

【実施例4】小麦粉80重量部、HAS粉末80重量部
をバター40重量部、砂糖75重量部とすり混ぜ、卵5
0重量部、牛乳10重量部を加えてよく混捏し、成型し
170℃で12〜15分焼成してHAS粉末入りビスケ
ットを得た。
Example 4 80 parts by weight of wheat flour and 80 parts by weight of HAS powder were rubbed with 40 parts by weight of butter and 75 parts by weight of sugar, and egg 5 was added.
0 parts by weight and 10 parts by weight of milk were added, kneaded well, molded, and baked at 170 ° C. for 12 to 15 minutes to obtain a HAS powder-containing biscuit.

【0028】[0028]

【実施例5】植物性マーガリン24重量部、砂糖18.
5重量部をすり混ぜ、卵を加え、HAS粉末22重量
部、薄力粉16重量部、蛋白成分12重量部、ビタミン
ミックス少量を加えて混捏し、バニラエッセンスを加え
成型し、150℃で約20分焼成してHAS粉末入りブ
ロック菓子を得た。
Example 5 24 parts by weight of vegetable margarine, sugar 18.
Mix 5 parts by weight, add eggs, add 22 parts by weight HAS powder, 16 parts by weight soft flour, 12 parts by weight protein component, add a small amount of vitamin mix, knead, add vanilla essence and mold, and bake at 150 ° C for about 20 minutes. Then, a block confectionery containing HAS powder was obtained.

【0029】[0029]

【実施例6】マグロ肉100重量部、食塩3重量部を加
えて混捏し、これにHAS粉末30重量部、砂糖1重量
部およびグルタミン酸ナトリウム、澱粉、香辛料、防腐
剤、木酢液、ビタミンA等を少量加え、さらにショート
ニングオイルを加え、ケーシングに充填密封し、85〜
88℃の熱湯に50分浸漬して加熱殺菌し、冷却してH
AS入りフイッシュソーセージを得た。
Example 6 100 parts by weight of tuna meat and 3 parts by weight of salt were added and kneaded, and 30 parts by weight of HAS powder, 1 part by weight of sugar and sodium glutamate, starch, spices, preservatives, wood vinegar, vitamin A, etc. Add a small amount, and then add shortening oil, fill and seal the casing, and
Immerse in 88 ° C hot water for 50 minutes, sterilize by heating, cool, and heat
A fish sausage containing AS was obtained.

【0030】[0030]

【実施例7】無塩バター45重量部、加塩バター45重
量部に砂糖70重量部を混ぜ、卵を加え、HAS粉末1
10重量部およびグルテン25重量部を切り混ぜ、成熟
し、180℃で15〜20分焼成してHAS入りクッキ
ーを得た。
Example 7 45 parts by weight of unsalted butter and 45 parts by weight of salted butter were mixed with 70 parts by weight of sugar, eggs were added, and HAS powder 1 was added.
10 parts by weight and 25 parts by weight of gluten were cut and mixed, matured and baked at 180 ° C. for 15 to 20 minutes to obtain a HAS-containing cookie.

【0031】[0031]

【実施例8】米12重量部を常法により吸水させ、煮沸
し、放冷後、味噌用種麹を散布して製麹した。これに大
豆30重量部を蒸煮したもの、HAS粉末20重量部お
よび種水を混合し、チョパーにかけた。これを醗酵タン
クに入れ、26〜28℃で約75日間温醸を行い、その
後味噌漉きしてHAS入り味噌を得た。
Example 8 12 parts by weight of rice was made to absorb water by a conventional method, boiled and allowed to cool, and then seed koji for miso was sprinkled to make koji. A mixture of 30 parts by weight of soybeans, 20 parts by weight of HAS powder and seed water was mixed with this, and the mixture was subjected to a chopper. This was put into a fermentation tank, brewed at 26 to 28 ° C. for about 75 days, and then strained to obtain HAS-containing miso.

【0032】[0032]

【実施例9】デューラム小麦粉100重量部、卵少量、
食塩3〜4重量部にHAS粉末10重量部を加えて攪拌
混捏し、生地を作り、薄片状に適宜成形して水分含量約
30%の生パスタを得た。この生パスタに、肉、チー
ズ、野菜等を詰め物として詰め、または詰め物を用いる
ことなく約100℃で2分間加熱して包装し、保存性あ
るパスタを得た。
[Example 9] 100 parts by weight of durum flour, a small amount of eggs,
HAS powder (10 parts by weight) was added to salt (3-4 parts by weight), and the mixture was stirred and kneaded to form a dough, which was appropriately shaped into flakes to obtain fresh pasta having a water content of about 30%. This raw pasta was packed with meat, cheese, vegetables, etc. as a stuffing, or was heated at about 100 ° C. for 2 minutes without using the stuffing and packaged to obtain a pasta having shelf life.

【0033】[0033]

【実施例10】HAS粉末3重量部と小麦粉97重量部
とを混合し、これに砂糖6重量部、食塩2重量部、ショ
ートニング5重量部を加え、さらに水68重量部を加え
ながら混捏する。これに酵母2重量部を水6重量部に溶
解して加え、よく混捏し、得られた生地を約27℃で2
時間醗酵させ、ガス抜きをし、さらに醗酵を続け、適当
な大きさに分割した。これをプルーフィングし、成形型
に入れ、200〜280℃で焙焼して、HAS入りパン
を得た。
Example 10 3 parts by weight of HAS powder and 97 parts by weight of wheat flour were mixed, and 6 parts by weight of sugar, 2 parts by weight of salt and 5 parts by weight of shortening were added thereto, and 68 parts by weight of water was added and kneaded. To this, 2 parts by weight of yeast was dissolved in 6 parts by weight of water, added and kneaded well.
Fermentation was carried out for a period of time, degassing was carried out, fermentation was further continued, and the product was divided into appropriate sizes. This was proofed, placed in a mold and roasted at 200-280 ° C to obtain a HAS-containing bread.

【0034】[0034]

【実施例11】バター100重量部を柔らかく練り砂糖
75重量部をすり混ぜ、さらに卵黄を加える。卵白を泡
立て砂糖25重量部を加えたメレンゲを混ぜ合わせ、小
麦粉50重量部、HAS粉末50重量部を加え混捏し
た。成形型に入れ170℃で15〜18分焼き、HAS
入りマドレーヌを得た。
[Example 11] 100 parts by weight of butter is kneaded gently, and 75 parts by weight of sugar is mixed by rubbing, and egg yolk is added. The egg whites were whipped and mixed with meringue to which 25 parts by weight of sugar was added, and 50 parts by weight of wheat flour and 50 parts by weight of HAS powder were added and kneaded. Put in mold and bake at 170 ℃ for 15-18 minutes, HAS
Got into Madeleine.

【0035】[0035]

【実施例12】クリームチーズ100重量部を湯煎して
滑らかになったところで牛乳16重量部、砂糖15重量
部、コーンスターチ10重量部、HAS粉末10重量
部、卵黄およびレモン汁を加えた。卵白を泡立て砂糖1
5重量部を添加したメレンゲを混捏し成形後、180℃
で30分程焼き、HAS入りチーズケーキを得た。
Example 12 When 100 parts by weight of cream cheese was boiled and smoothed, 16 parts by weight of milk, 15 parts by weight of sugar, 10 parts by weight of corn starch, 10 parts by weight of HAS powder, egg yolk and lemon juice were added. Whipped egg whites with sugar 1
After kneading and molding the meringue with 5 parts by weight added, 180 ° C
It was baked for about 30 minutes to obtain a cheese cake containing HAS.

【0036】[0036]

【発明の効果】HASは、上述のように、明らかに潰瘍
性大腸炎抑制作用を有しており、これを他の食品材料に
配合してなる組成物を種々の形体の食品として食するこ
とにより、潰瘍性大腸炎、特に慢性潰瘍性大腸炎を治療
もしくは予防することができる。また、HASは食物繊
維に比べて食感、味、色が良いため、これを配合した食
品は通常の食品と同様に摂取することができ、多量ある
いは長期間にわたる摂取が可能である。
Industrial Applicability As described above, HAS has an apparent ulcerative colitis-suppressing action, and the composition obtained by mixing it with other food materials can be eaten as various forms of food. Thus, ulcerative colitis, especially chronic ulcerative colitis can be treated or prevented. Further, since HAS has a better texture, taste, and color than dietary fiber, foods containing this can be taken in the same way as ordinary foods, and can be taken in large amounts or over a long period of time.

【図面の簡単な説明】[Brief description of drawings]

【図1】試験例1の大腸の肉眼的所見(マクロスコア;
0〜5)を示す。
FIG. 1 Macroscopic findings of the large intestine of Test Example 1 (macro score;
0-5) is shown.

【図2】試験例1の各試験飼料を投与している間のラッ
トの体重変化を示す。
FIG. 2 shows changes in body weight of rats during administration of each test feed of Test Example 1.

【図3】試験例1の各試験飼料を投与後のミエロペルオ
キシダーゼ活性量を示す。
FIG. 3 shows the amount of myeloperoxidase activity after administration of each test feed of Test Example 1.

【図4】試験例1の各試験飼料を投与後の血清トランス
グルタミナーゼ活性を示す。
FIG. 4 shows serum transglutaminase activity after administration of each test feed of Test Example 1.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI C08B 30/20 C08B 30/20 (72)発明者 笠岡 誠一 東京都板橋区蓮根3−18−13 ルーミー 蓮根502号 (72)発明者 桐山 修八 東京都三鷹市牟礼4−1−4 (56)参考文献 特表 平10−504189(JP,A) 国際公開94/014342(WO,A1) (58)調査した分野(Int.Cl.7,DB名) A61K 31/00 - 33/44 CA(STN)─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 7 Identification code FI C08B 30/20 C08B 30/20 (72) Inventor Seiichi Kasaoka 3-18-13 Hasune, Itabashi-ku, Tokyo Rumi Hasune 502 (72) Inventor Shuhachi Kiriyama 4-1-4 Mure, Mitaka City, Tokyo (56) References Tokukaihei 10-504189 (JP, A) International Publication 94/014342 (WO, A1) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 31/00-33/44 CA (STN)

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ハイアミローススターチを有効成分とし
て含有することを特徴とする潰瘍性大腸炎抑制組成物。
但し、ゲル化した軟らかい構造を有するハイアミロース
スターチを除く。
1. A composition for suppressing ulcerative colitis, which comprises high amylose starch as an active ingredient.
However, high amylose having a gelled soft structure
Excluding starch.
【請求項2】 ハイアミローススターチが、アミロース
を40〜90重量%含有するものであり、且つ、総食物
繊維定量法によって得られる難消化性成分が25〜40
重量%を示す、請求項1に記載した組成物。
2. The high amylose starch contains amylose in an amount of 40 to 90% by weight, and the indigestible component obtained by the total dietary fiber assay is 25 to 40.
The composition according to claim 1, which exhibits a weight percentage.
【請求項3】 ハイアミローススターチが、アミロース
を70〜90重量%含有するものであり、且つ、総食物
繊維定量法によって得られる難消化成分が25〜40重
量%を示す、請求項1に記載した組成物。
3. The high-amylose starch contains 70 to 90% by weight of amylose, and the indigestible component obtained by the total dietary fiber quantification method shows 25 to 40% by weight. Composition.
【請求項4】 組成物が食品である請求項1〜3のいず
れかに記載の組成物。
4. The composition according to claim 1, which is a food product.
【請求項5】 ハイアミローススターチを有効成分とし
て含有する10〜50重量%含有する請求項1〜4のい
ずれかに記載の組成物。
5. The composition according to claim 1, which contains 10 to 50% by weight of high amylose starch as an active ingredient.
JP03015095A 1995-01-26 1995-01-26 Ulcerative colitis suppressing composition Expired - Fee Related JP3494320B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03015095A JP3494320B2 (en) 1995-01-26 1995-01-26 Ulcerative colitis suppressing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03015095A JP3494320B2 (en) 1995-01-26 1995-01-26 Ulcerative colitis suppressing composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003280195A Division JP2004026839A (en) 2003-07-25 2003-07-25 Composition for inhibiting ulcerative colitis

Publications (2)

Publication Number Publication Date
JPH08198757A JPH08198757A (en) 1996-08-06
JP3494320B2 true JP3494320B2 (en) 2004-02-09

Family

ID=12295742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03015095A Expired - Fee Related JP3494320B2 (en) 1995-01-26 1995-01-26 Ulcerative colitis suppressing composition

Country Status (1)

Country Link
JP (1) JP3494320B2 (en)

Also Published As

Publication number Publication date
JPH08198757A (en) 1996-08-06

Similar Documents

Publication Publication Date Title
JP5865296B2 (en) Compositions containing dietary fat complexing agents and methods for their use
JP5189945B2 (en) Diet composition and method for producing diet food and pet food using the same
JP2008079606A (en) Raw material powder for processed foods
US5384144A (en) Psyllium enriched pasta products and method for making same
JPH03254653A (en) Material for food and its production
WO2002052945A1 (en) Highly nutritious baked products
US5384136A (en) Psyllium-enriched dough products and method for making the same
JPS59187745A (en) Novel type of food material
JP2008178398A (en) Lactic acid fermentation product of animal protein, method for producing the same and food, and health food containing the lactic acid fermentation product
RU2356246C2 (en) Complex additive with biologically active properties for bakery products based on soya drink and\or soya okara and product that contains it
WO2013054309A2 (en) Prepared food for functional food
JP3494320B2 (en) Ulcerative colitis suppressing composition
US20070264392A1 (en) Protein-Rich Baked Food and Process for Producing the Same
JP2004026839A (en) Composition for inhibiting ulcerative colitis
JP6129623B2 (en) General nutrition food containing branched chain amino acids
HU226088B1 (en) Diabetic flour, flourmix and admixture free from bran and process for producing of baking product especially bread, rolls and cake and using these
JPH08198759A (en) Composition for inhibiting breast cancer
RU2723961C1 (en) Butter oatmeal biscuit on vegetable oils and milk whey
JP2002281921A (en) Low-protein starch food
JP3708500B2 (en) High protein baked food and method for producing the same
KR100639839B1 (en) Compositions comprising dietary fat complexer and methods for their use
JP3083973U (en) Seasoned stewed kelp
KR20240106788A (en) A process for the preparation of gluten-free grain bread containing aster scaber and gluten-free grain bread containing aster scaber prepared therefrom
JP2010095468A (en) Muscle amount reduction inhibitor
JPH02211837A (en) Noodles

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071121

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081121

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees